Yayınlanmış 1 Ocak 2012
| Sürüm v1
Dergi makalesi
Açık
Comparison of Ga-68-DOTATATE and Ga-68-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
Oluşturanlar
- 1. Istanbul Univ, Dept Nucl Med, Cerrahpasa Med Fac, Istanbul, Turkey
- 2. Istanbul Univ, Dept Pharmaceut Technol, Fac Pharm, Istanbul, Turkey
- 3. Med Univ Innsbruck, Clin Dept Nucl Med, Innsbruck, Austria
Açıklama
Recent studies have suggested that positron emission tomography (PET) imaging with Ga-68-labelled DOTA-somatostatin analogues (SST) like octreotide and octreotate is useful in diagnosing neuroendocrine tumours (NETs) and has superior value over both CT and planar and single photon emission computed tomography (SPECT) somatostatin receptor scintigraphy (SRS). The aim of the present study was to evaluate the role of Ga-68-DOTA-1-NaI3-octreotide (Ga-68-DOTANOC) in patients with SST receptor-expressing tumours and to compare the results of Ga-68-DOTA-D-Phe(1)-Tyr(3)-octreotate (Ga-68-DOTATATE) in the same patient population.
Dosyalar
bib-422b58e7-1a1f-445f-a2d4-9aa0b4d64f10.txt
Dosyalar
(303 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:aaa2de926523df18fadd8497689b0994
|
303 Bytes | Ön İzleme İndir |